Vaccines against Influenza Virus
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Influenza Virus Vaccines".
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 36987
Special Issue Editor
Interests: arboviruses; influenza virus; macromolecular structure-function; proteomics, reovirus; virus-host interactions; Zika virus
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Influenza can cause viral pneumonia, especially in the elderly, the chronically ill and the very young, which can lead to breathing difficulties and serious complications. Another danger of influenza is the aggravation of pre-existing chronic diseases, including heart disease, pneumonia, kidney disease and diabetes, leading to organ failure. More seriously, influenza could cause a potential pandemic. Influenza vaccination is the most effective measure to prevent influenza. However, the understanding of influenza vaccine is far from enough.
We are pleased to invite you to contribute this special issue on influence vaccine. The issue aims to discuss the vaccine and related issues, including the epidemic characteristics of influenza under the COVID-19 pandemic, the impact of specific prevention strategies on the epidemic trend, the cross-protection of influenza vaccine, influenza virus variation and control strategies, and the development of new influenza vaccine, etc.
This Special Issue aims to understand:
- Epidemiology of influenza in the context of COVID-19;
- Impact of prevention of vaccination
- Cross protection of vaccination
- Influenza virus variation and the control strategies
- Innovation and vaccine research and development
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but not limited to) the following: Epidemiology, clinical trial, Meta-analysis, real world evaluation on influence vaccine.
We look forward to receiving your contributions.
Prof. Dr. Kevin Coombs
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccines
- prevention
- effectiveness
- development
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.